Trade Summary

Yesterday, Soni Manmeet Singh, serving as COO and CFO at Summit Therapeutics Inc. (SMMT), purchased 50,000 shares at $14.45 per share, for a total transaction value of $722,250.00. Following this transaction, Soni Manmeet Singh now holds 3,123,603 shares of SMMT.

This purchase represents a 1.63% increase in Soni Manmeet Singh's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, June 4, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, June 4, 2026 at 4:40 PM ET, meaning the disclosure happened on the same day as the trade.

Summit Therapeutics Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.